CLINICAL TRIALS PROFILE FOR LOXITANE IM
✉ Email this page to a colleague
All Clinical Trials for LOXITANE IM
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00648778 ↗ | Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mg | Completed | Mylan Pharmaceuticals | Phase 1 | 2003-01-01 | The objective of this study was to investigate the bioequivalence of Mylan loxapine succinate 25 mg capsules to Watson Loxitane 25 mg capsules following a single, oral 25 mg (1 x 25 mg) dose administration under fasting conditions. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LOXITANE IM
Condition Name
Clinical Trial Locations for LOXITANE IM
Trials by Country
Clinical Trial Progress for LOXITANE IM
Clinical Trial Phase
Clinical Trial Sponsors for LOXITANE IM
Sponsor Name